You are here

Article Text

Article menu

Download PDFPDF

Electronic pages
Correspondence
Correspondence response
Response to: ‘Paracetamol: is all the concern valid?’ by Schwarz and Mullins
Free
  1. Emmert Roberts1,
  2. Philip G Conaghan2
  1. 1Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK
  2. 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds UK
  1. Correspondence to Dr Emmert Roberts, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, Weston Education Centre, 10 Cutcombe Rd, London SE5 9RJ, UK; emmert.roberts{at}slam.nhs.uk

https://doi.org/10.1136/annrheumdis-2015-207691

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank Drs Schwarz and Mullins for their comments1 on our paper,2 and we agree with many of their points. The absolute risks of the studied adverse events were small, and paracetamol still has a better adverse event profile than traditional non-steroidal anti-inflammatory drugs (NSAIDs) or opioids. However, we would like to highlight that there are also non-pharmacological alternatives for chronic pain conditions, especially those of the musculoskeletal system: muscle strengthening, increased activity and weight loss if overweight.3 …

    View Full Text

    Linked Articles

    • Electronic pages
      Paracetamol: is all the concern valid?
      Evan S Schwarz Michael E Mullins
      Annals of the Rheumatic Diseases 2015; 74 e48-e48 Published Online First: 09 Apr 2015. doi: 10.1136/annrheumdis-2015-207644